For example, in a recent genome-wide screen testing resistance to BRAF inhibitors in melanoma cells, CRISPR/Cas9-mediated activation of more than 10,000 lncRNAs revealed 16 candidate loci conferring resistance to BRAF inhibition (25). The gene discussed is BRAF; the disease is melanoma.